Hurtado-Guerrero, Isaac
Pinto-Medel, Maria Jesus http://orcid.org/0000-0002-1129-7415
Urbaneja, Patricia
Rodriguez-Bada, Jose Luis
Ortega-Pinazo, Jesús
Serrano, Pedro http://orcid.org/0000-0002-3414-2707
Fernández, Óscar
Leyva, Laura
Oliver-Martos, Begoña
Article History
Received: 8 August 2017
Accepted: 17 November 2017
First Online: 29 November 2017
Competing Interests
: Pedro Serrano Castro has received honoraria or served as a paid consultant for BIAL, EISAI, ESTEVE, Juste, UCB-Pharma, Sanofi and Shire. Oscar Fermnandez reports receiving honoraria as a consultant in advisory boards, as chair/lecturer in meetings, from participation in clinical trials and other research projects promoted by Actelion, Allergan, Almirall, Bayer-Schering, Biogen, Merck Serono, Novartis, Sanofi Genzyme, and Teva, and research support from the Hospital Foundation FIMABIS; he also serves as editor of the Revista Española de Esclerosis Múltiple.